Report Open Access

Statistical review of Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Kahan, Brennan; Hood, Kerry; Dahly, Darren


GeoJSON Export

{
  "type": "FeatureCollection", 
  "features": []
}
801
179
views
downloads
All versions This version
Views 801801
Downloads 179179
Data volume 36.5 MB36.5 MB
Unique views 761761
Unique downloads 172172

Share

Cite as